Please login to the form below

Not currently logged in

BMS hires Roche's Mike Burgess to lead drug discovery

Was previously interim head of research and early development at Swiss pharma company

Mike Burgess, BMSMike Burgess has left Roche to become senior VP, discovery medicine and clinical pharmacology at Bristol-Myers Squibb.

Most recently, he was interim head of research and early development at Roche - a position now occupied by John Reed - and had previously led the Swiss pharma firm's oncology discovery and translational area at the same time as serving as head of global large molecule research.

In his new role, he will report to Dr Francis Cuss, senior VP research, R&D, and will be a member of BMS's research senior leadership team.

“As a physician scientist with a PhD in molecular biology, clinical experience in paediatrics and paediatric oncology, and extensive pharmaceutical industry and leadership experience, I believe Mike will be an important addition to our research and development organisation,” said Dr Cuss.

“Mike's broad clinical expertise, cross-therapeutic global team leadership and proven operational excellence will enable Bristol-Myers Squibb to continue to execute its strategy of ensuring sustainable delivery of an innovative pipeline of new medicines for patients.”

Prior to joining Roche, Dr Burgess was a medical fellow at Lilly, having completed his PhD at the University of Bristol in the UK.

21st January 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...